Sam Dajani is the Chairman and Chief Executive Officer of Vela Diagnostics. He is currently responsible for the overall operation of Vela Diagnostics (Intl.) and Great Basin Scientific (Intl.).
Sam has over 30 years of management, strategic and operational experience in the Biotechnology, Speciality Chemicals and Pharmaceutical industry. Before joining Vela Diagnostics as Chief Executive Officer (CEO), he held senior positions at several multi-national companies such as Director of Sales and Marketing at Pfizer Inc., General Manager at Kaneka Corporation, President of Danaher Corporation (APAC), Global Chief Operating Officer (COO) at Cathay Industrial Biotech Ltd., and Global Chief Executive Officer (CEO) at Cyklop International.
Sam obtained his BSc in Chemistry, and MSc in Organic Chemistry from Baylor University, and attended Executive MBA Programs at Columbia University.